Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany’s New Non-Substitution Drug List No Big Bang For Pharma

This article was originally published in The Pink Sheet Daily

Executive Summary

Germany will have its first list of non-substitutable pharmaceuticals since the introduction of discount contracts, but the benefit it offers to original product manufacturers will be severely limited.

You may also be interested in...

European Notebook: Price Freezes, European Elections To Feature In 2014

This month’s European Notebook scans the horizon for European legislative and regulatory changes affecting the pharmaceutical industry in the next 12 months, including drug price freezes in Germany and the U.K., the heated debate over clinical trial data transparency, the start of the EU unitary patent, and more.

AstraZeneca Blames Germany’s Tender System For Influenza Vaccine Shortages

AstraZeneca says that shortages of influenza vaccines in Germany are a direct result of the tendering process there, which has blocked the firm’s Fluenz nasal spray product from being prescribed in several federal states.

Germany's Discount Contracts Are Changing The Pharma Market Landscape

Regional firm wins an important tender, but at a discount that is so steep it attacks the process as creating "only losers."


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts